VERTEX PHARMACEUTICALS INC / MA — Cash Flow Charts
8 quarters of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Capital Allocation
How management deploys cash: investing in the business (Capex + M&A) vs returning to shareholders (Buybacks + Dividends).
Capital Allocation Waterfall
Buybacks vs Stock-Based Comp
Cash Flow
Cash Flow by Activity
Operating Cash Flow↓-14.8% -$87M
$498M
Free Cash Flow↓-29.1% -$143M
$349M
Investing Cash Flow↑+97.4% +$2.08B
$-56M
Financing Cash Flow↓-90.3% -$323M
$-680M
Capex↑+61.3% +$57M
$149M
Acquisitions
$0
Stock Buybacks↓-69.3% -$290M
$128M
Stock-Based Comp↓-6.1% -$10M
$158M
Debt Issued
—
Debt Repaid
—
D&A↑+19.8% +$9M
$56M
SBC Allocated Expense↓-6.1% -$10M
$158M